Search Result "RXFP1"


The Roles of the A- and B-Chains of Human Relaxin-2 and -3 on Their Biological Activity

Journal: Current Protein & Peptide Science
Volume: 11 Issue: 8 Year: 2010 Page: 719-724
Author(s): Mohammed Akhter Hossain, John D. Wade

The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes

Journal: Protein & Peptide Letters
Volume: 20 Issue: 9 Year: 2013 Page: 1029-1038
Author(s): Su Ee Wong, Chrishan S. Samuel, Darren J. Kelly, Yuan Zhang, Gavin J. Becker, Tim D. Hewitson

Review Article

Site-related Effects of Relaxin in the Gastrointestinal Tract Through Nitric Oxide Signalling: An Updated Report

Journal: Current Protein & Peptide Science
Volume: 18 Issue: 12 Year: 2017 Page: 1254-1262
Author(s): Rachele Garella,Roberta Squecco,Maria Caterina Baccari

Relaxin Receptors - New Drug Targets for Multiple Disease States

Journal: Current Drug Targets
Volume: 8 Issue: 1 Year: 2007 Page: 91-104
Author(s): E. T. Van Der Westhuizen, R. J. Summers, M. L. Halls, R. A. D. Bathgate, P. M. Sexton

Review Article open access plus

Human Recombinant Relaxin (Serelaxin) as Anti-fibrotic Agent: Pharmacology, Limitations and Actual Perspectives

Journal: Current Molecular Medicine
Volume: 22 Issue: 3 Year: 2022 Page: 196-208
Author(s): Chiara Sassoli,Silvia Nistri,Flaminia Chellini,Daniele Bani

Journal: Protein & Peptide Letters
Volume: 18 Issue: 3 Year: 2011 Page: 220-229
Author(s): Linda Jiaying Chan, Mohammed Akhter Hossain, Chrishan S. Samuel, Frances Separovic, John D. Wade

Relaxin as a Cardiovascular Drug: A Promise Kept

Journal: Current Drug Safety
Volume: 6 Issue: 5 Year: 2011 Page: 324-328
Author(s): Daniele Bani, Mario Bigazzi

Review Article

Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection

Journal: Current Drug Targets
Volume: 20 Issue: 5 Year: 2019 Page: 522-539
Author(s): Surovi Saikia,Manobjyoti Bordoloi,Rajeev Sarmah

Clinical Profile of Relaxin, a Possible New Drug for Human Use

Journal: Current Drug Safety
Volume: 4 Issue: 3 Year: 2009 Page: 238-249
Author(s): Daniele Bani, Samuel K. Yue, Mario Bigazzi

Relaxin as a Cardiovascular Hormone: Physiology, Pathophysiology and Therapeutic Promises

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5 Issue: 2 Year: 2007 Page: 101-108
Author(s): Silvia Nistri, Mario Bigazzi, Daniele Bani

Previous   Next

Go To   Results 1 - 1 of 18

Apply Filters

Volume Years
Article Type
    Publication Title
    Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy